Takeda Pharmaceutical
TAK
#469
Rank
$47.07 B
Marketcap
$15.07
Share price
-1.76%
Change (1 day)
14.34%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : $48.77 Billion USD

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are $48.77 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-03-31$51.74 B-9.24%
2023-03-31$57.01 B-7.37%
2022-03-31$61.55 B-11.87%
2021-03-31$69.84 B-7.23%
2020-03-31$75.28 B-2.91%
2019-03-31$77.54 B294.61%
2018-03-31$19.65 B-8.82%
2017-03-31$21.55 B33.71%
2016-03-31$16.11 B-7.44%
2015-03-31$17.41 B-11.4%
2014-03-31$19.65 B8.09%
2013-03-31$18.18 B4.75%
2012-03-31$17.35 B122.69%
2011-03-31$7.79 B11.08%
2010-03-31$7.01 B-1.99%
2009-03-31$7.15 B39.03%
2008-03-31$5.14 B-0.81%
2007-03-31$5.19 B-11.86%
2006-03-31$5.89 B16.57%
2005-03-31$5.05 B-5.49%
2004-03-31$5.34 B28.1%
2003-03-31$4.17 B2.07%
2002-03-31$4.08 B4.05%
2001-03-31$3.92 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$115.56 B 136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$62.18 B 27.48%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
$117.39 B 140.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$61.48 B 26.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
$1.08 B-97.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
$1.82 B-96.26%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
$83.16 B 70.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$60.79 B 24.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$66.72 B 36.79%๐Ÿ‡บ๐Ÿ‡ธ USA